First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Henderson
Venthera, Inc., a BridgeBio company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital/uams
Little Rock, Arkansas, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Dermatology Cosmetic Laser Medical Associates of la Jolla
San Diego, California, United States
- Children'S Hospital of Colorado
Aurora, Colorado, United States
- Indiana University Health (riley Children'S Hospital and University Hospital)
Indianapolis, Indiana, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Duke University
Raleigh, North Carolina, United States
- Cincinnatti Children'S Hospital
Cincinnati, Ohio, United States
- University Hospitals- Cleveland Medical Center
Cleveland, Ohio, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Texas Children'S Hospital
Houston, Texas, United States
- Texas Dermatology and Laser Specialists
San Antonio, Texas, United States
- University of Virginia Department of Dermatology
Charlottesville, Virginia, United States
- University of Wisconsin-Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2020
- Primary completion
- 13 Apr 2022
- Completion
- 13 Apr 2022
- Last update posted
- 4 Aug 2022
- Registered enrollment
- 15
- Registry id
- NCT04409145
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.